|View printer-friendly version|
PACE, the acronym for
“Following a rigorous selection and interview process, we are pleased to have been chosen as the Medication Risk Mitigation™ and safety provider for
CareKinesis will provide its Medication Risk Mitigation, e-prescribing technology platform, along with pharmacy services. Multi-drug interaction-informed adherence packaging will be used to help avoid preventable adverse drug events, the 4th leading cause of death in the U.S. amongst older adults, according to the
Joining Ms. McDaniel’s, Total Life Healthcare’s Finance Director, Mr.
PACE is a growing healthcare service in the
PACE organizations nationwide rely on CareKinesis technology, science, and pharmacists who are board-certified in geriatrics, to improve medication outcomes and adherence and to reduce participant hospitalizations.
CareKinesis partners with healthcare organizations to provide personalized medication therapy management and pharmacy services for high-risk populations. The results are enhanced medication-related outcomes and greater operational efficiency. CareKinesis delivers individually customized medication services using unique robotic technology and a proprietary web-based electronic medication management and reporting platform, EireneRx™. It is the first, national PACE-specific pharmacy and the market leader. For more information, please visit www.carekinesis.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the